180 related articles for article (PubMed ID: 37428914)
1. KRAS mutation-driven angiopoietin 2 bestows anti-VEGF resistance in epithelial carcinomas.
Hosaka K; Andersson P; Wu J; He X; Du Q; Jing X; Seki T; Gao J; Zhang Y; Sun X; Huang P; Yang Y; Ge M; Cao Y
Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2303740120. PubMed ID: 37428914
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition.
Hofmann I; Baum A; Hofmann MH; Trapani F; Reichel-Voda C; Ehrensperger D; Aichinger M; Ebner F; Budano N; Schweifer N; Sykora M; Depla E; Boucneau J; Gschwind A; Kraut N; Hilberg F; Künkele KP
J Pharmacol Exp Ther; 2023 Mar; 384(3):331-342. PubMed ID: 36241203
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.
Saito M; Watanabe J; Fujisawa T; Kamata Y; Nishimura Y; Arai T; Miyamoto T; Obokata A; Kuramoto H
Eur J Gynaecol Oncol; 2006; 27(2):129-34. PubMed ID: 16620053
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.
Hangai M; Murata T; Miyawaki N; Spee C; Lim JI; He S; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1617-25. PubMed ID: 11381069
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
7. Acute resistance exercise increases skeletal muscle angiogenic growth factor expression.
Gavin TP; Drew JL; Kubik CJ; Pofahl WE; Hickner RC
Acta Physiol (Oxf); 2007 Oct; 191(2):139-46. PubMed ID: 17565567
[TBL] [Abstract][Full Text] [Related]
8. The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer.
Leong A; Kim M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217955
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of murine macrophage angiopoietin-2.
Hubbard NE; Lim D; Mukutmoni M; Cai A; Erickson KL
Cell Immunol; 2005 Apr; 234(2):102-9. PubMed ID: 16045902
[TBL] [Abstract][Full Text] [Related]
10. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
Li Q; Xu B; Fu L; Hao XS
J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
[TBL] [Abstract][Full Text] [Related]
11. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2.
Geva E; Ginzinger DG; Zaloudek CJ; Moore DH; Byrne A; Jaffe RB
J Clin Endocrinol Metab; 2002 Sep; 87(9):4213-24. PubMed ID: 12213874
[TBL] [Abstract][Full Text] [Related]
12. Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model.
Lange C; Tetzner R; Strunz T; Rittenhouse KD
Transl Vis Sci Technol; 2023 May; 12(5):17. PubMed ID: 37191621
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro.
Buchanan CF; Szot CS; Wilson TD; Akman S; Metheny-Barlow LJ; Robertson JL; Freeman JW; Rylander MN
J Cell Biochem; 2012 Apr; 113(4):1142-51. PubMed ID: 22095586
[TBL] [Abstract][Full Text] [Related]
15. BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2.
Wang F; Li C; Han F; Chen L; Zhu L
Aging (Albany NY); 2021 Nov; 13(22):24675-24685. PubMed ID: 34815366
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma.
Zhou J; Zhang ZX; Zhao H; Zhu DM; Zhang Y; Li DC
Technol Cancer Res Treat; 2011 Aug; 10(4):361-9. PubMed ID: 21728393
[TBL] [Abstract][Full Text] [Related]
17. The expression analyses of GSK3B, VEGF, ANG1, and ANG2 in human brain microvascular endothelial cells treated with the synthetic cannabinoid XLR-11.
Al-Eitan L; Alahmad S
Gene; 2023 Aug; 878():147585. PubMed ID: 37355149
[TBL] [Abstract][Full Text] [Related]
18. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
19. Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2.
Gao W; Sweeney C; Walsh C; Rooney P; McCormick J; Veale DJ; Fearon U
Ann Rheum Dis; 2013 Jun; 72(6):1080-8. PubMed ID: 23161900
[TBL] [Abstract][Full Text] [Related]
20. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
Loges S; Heil G; Bruweleit M; Schoder V; Butzal M; Fischer U; Gehling UM; Schuch G; Hossfeld DK; Fiedler W
J Clin Oncol; 2005 Feb; 23(6):1109-17. PubMed ID: 15718307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
